Ernesto Sparrelid
banner
sparrelid.bsky.social
Ernesto Sparrelid
@sparrelid.bsky.social
Current Chair of the Department for Upper Abdominal Diseases @KarolinskaUnsju, former Head of @HpbKarolinska, Associate Professor @karolinskainst
Reposted by Ernesto Sparrelid
Thank you for a great collaborative study: @sparrelid.bsky.social, Helena Taflin, Hanna Jacobsson, Ghada Nouairia, Niklas Björkström, Martin Cornillet!
May 5, 2025 at 6:59 PM
Reposted by Ernesto Sparrelid
Congratulations Antonio Akiki to your first author paper 🙌🏻📑 now in EJSO! Very happy to have this study out, validating plasma CSF1 as a novel, well-calibrated preoperative prognostic factor in intrahepatic cholangiocarcinoma @ki.se @hpb-karolinska.bsky.social

www.ejso.com/article/S074...
#HPBSky
External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma
Long-term prognosis after resection for intrahepatic cholangiocarcinoma (iCCA) remains poor and the preoperative oncological risk assessment is difficult. Two immune system-related plasma proteins, co...
www.ejso.com
May 5, 2025 at 6:59 PM
Reposted by Ernesto Sparrelid
Very proud to have our study out in @bjsopen.bsky.social from my fellowship at CIH 🇯🇵

❓Reasons for differences in outcome for pCCA? Would we see differences in demography, in tumors or differing treatment for similar tumors? Short answer: all of the above☝🏼 #HPBSky academic.oup.com/bjsopen/arti...
Western and Eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre study
This study analysed current outcomes after resection for perihilar cholangiocarcinoma in a large bi-institutional Western–Eastern cohort to identify progno
academic.oup.com
April 9, 2025 at 6:30 PM